Yahr
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
-
- Neuroscience and Neuropharmacology Research
- Genetic Neurodegenerative Diseases
- Neurotransmitter Receptor Influence on Behavior
Papers in
- Neurology 15
- Parkinson's Disease Mechanisms and Treatments 8
- Neurological disorders and treatments 4
- Neurofibromatosis and Schwannoma Cases 1
-
- Metabolism and Genetic Disorders 4
- Co-authors
- Duvoisin Rc (7 shared papers)Kabat Ea (2 shared papers)D M Cowen (1 shared paper)Iván Bódis-Wollner (1 shared paper)J Pecci-Saavedra (1 shared paper)Tauba Pasik (1 shared paper)P Pasik (1 shared paper)Gil’ad N. Cohen (2 shared papers)
- Journals
- PubMed (33 papers)
- Partner nations
- United States
In The Last Decade
Yahr
32 papers receiving 383 citations
Peers
Comparison fields: 5 of 77
- Neurology 262
- Cellular and Molecular Neuroscience 133
- Psychiatry and Mental health 62
- Biological Psychiatry 9
- Rheumatology 39
Countries citing papers authored by Yahr
This map shows the geographic impact of Yahr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yahr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yahr more than expected).
Fields of papers citing papers by Yahr
This network shows the impact of papers produced by Yahr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yahr. The network helps show where Yahr may publish in the future.
Co-authors
The 15 scholars most cited alongside Yahr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. | 1968 | 74 |
| 2 | Determination of plasma and cerebrospinal fluid levels of dilantin in the human. | 1960 | 52 |
| 3 | Neurological aspects of neurofibromatosis. | 1981 | 33 |
| 4 | Parkinson's disease and long-term levodopa therapy. | 1987 | 29 |
| 5 | Childhood lupus erythematosus. A clinical and pathological study of the neurological manifestations. | 1960 | 28 |
| 6 | Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486). | 1971 | 25 |
| 7 | Serotonin in pallidal neuronal circuits: an immunocytochemical study in monkeys. | 1984 | 24 |
| 8 | Variations in the "on-off" effect. | 1974 | 23 |
| 9 | Encephalopathy associated with carcinoma. | 1965 | 21 |
| 10 | Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration. | 1984 | 20 |
| 11 | Nonmotor functions of the basal ganglia. | 1984 | 18 |
| 12 | Parkinson's disease. The L-dopa era. | 1993 | 14 |
| 13 | Neurological diseases with elevation of cerebrospinal fluid gamma globulin: a critical review. | 1962 | 13 |
| 14 | Influenza A virus as a possible cause of postencephalitic Parkinsonism. | 1973 | 10 |
| 15 | L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients. | 1990 | 10 |
| 16 | Parkinson's disease--overview of its current status. | 1977 | 8 |
| 17 | R-(-)-deprenyl and parkinsonism. | 1987 | 8 |
| 18 | Pyridoxine, DOPA, and Parkinsonism. | 1972 | 7 |
| 19 | Medical therapy of Parkinsonism. | 1968 | 6 |
| 20 | Central neurocytoma: An unusual intraventricular tumor. | 1995 | 6 |
About Yahr
Yahr is a scholar working on Neurology, Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Genetics and Rheumatology, having authored 33 papers that have together received 463 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (8 papers), Metabolism and Genetic Disorders (4 papers), Neurological disorders and treatments (4 papers), Neurological and metabolic disorders (3 papers), Glioma Diagnosis and Treatment (3 papers), Click Chemistry and Applications (1 paper), Neurofibromatosis and Schwannoma Cases (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Neurology (262 citations), Cellular and Molecular Neuroscience (133 citations), Psychiatry and Mental health (62 citations), Biological Psychiatry (9 citations) and Rheumatology (39 citations). Yahr has collaborated with scholars based in United States. Frequent co-authors include Duvoisin Rc, Kabat Ea, D M Cowen, Iván Bódis-Wollner, J Pecci-Saavedra, Tauba Pasik, P Pasik, Gil’ad N. Cohen, K Sivakumar and Herbert Barden. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.